Multi Defender Vonti

Symbol: RMBKZV
ISIN: CH1377799205
Issuer:
Bank Vontobel
Trade

Chart

    
    

SIX Structured Products trading

SIX Structured Products Bid Ask Notation
Please note that data is only available after start of trading.

Performance

Closing prev. day 93.40
Diff. absolute / % -0.90 -0.99%

Determined prices

Last Price 91.20 Volume 5,000
Time 10:15:41 Date 20/11/2024

More Product Information

Core Data

Name Multi Defender Vonti
ISIN CH1377799205
Valor 137779920
Symbol RMBKZV
Quotation in percent Yes
Coupon p.a. 5.50%
Coupon Premium 4.85%
Coupon Yield 0.65%
Type Multi Barrier Reverse Convertibles
SVSP Code 1230
Barrier reached No
COSI Product No
Exercise type European
Currency Swiss Franc
First Trading Date 17/09/2024
Date of maturity 22/09/2025
Last trading day 15/09/2025
Settlement Type Path-dependent
IRS 871m Potentially in scope for combined transactions
Currency safeguarded Yes
Pricing Clean
Issuer Bank Vontobel

Key data

Ask Price (basis for calculation) 91.9000
Maximum yield 13.66%
Maximum yield p.a. 16.40%
Sideways yield 13.66%
Sideways yield p.a. 16.40%

market maker quality Date: 20/11/2024

Average Spread 1.52%
Last Best Bid Price 90.20 %
Last Best Ask Price 91.00 %
Last Best Bid Volume 100,000
Last Best Ask Volume 100,000
Average Buy Volume 27,850
Average Sell Volume 27,816
Average Buy Value 25,132 CHF
Average Sell Value 25,367 CHF
Spreads Availability Ratio 97.95%
Quote Availability 97.95%

Underlyings

Name Eli Lilly & Co. Ypsomed Hldg. AG Novo Nordisk AS (B)
ISIN US5324571083 CH0019396990 DK0062498333
Price 660.00 CHF 357.00 CHF 100.92 EUR
Date 22/11/24 10:28 22/11/24 17:30 22/11/24 22:59
Cap 923.71 USD 423.00 CHF 918.50 DKK
Distance to Cap -171.25 -62.5 -196.7
Distance to Cap in % -22.76% -17.34% -27.25%
Is Cap Level reached No No No
Barrier 544.989 USD 249.57 CHF 541.92 DKK
Distance to Barrier 207.471 110.93 179.88
Distance to Barrier in % 27.57% 30.77% 24.92%
Is Barrier reached No No No

Please wait...
The data push was deactivated due to a timeout. Please click "Refresh page" to continue.